Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Insider Filings by transaction date..
View:
Post by Mole101 on Nov 10, 2020 4:22pm

Insider Filings by transaction date..

  • Nov 05, 2020 (filed on Nov 10, 2020)
    Insider Name:
    Kirwin, Patrick D.
    Ownership Type:
    Direct Ownership
    Securities:
    Special Warrants
    Nature of Transaction:
    16 - Acquisition or disposition under a prospectus exemption
    # or value acquired/disposed of:
    200,000
    Price:
    $0.12
  • Nov 05, 2020 (filed on Nov 10, 2020)
    Insider Name:
    Wyman, William Williams
    Ownership Type:
    Direct Ownership
    Securities:
    Special Warrants
    Nature of Transaction:
    16 - Acquisition or disposition under a prospectus exemption
    # or value acquired/disposed of:
    272,916
    Price:
    $0.12
  • Nov 05, 2020 (filed on Nov 10, 2020)
    Insider Name:
    Goldstein, Elliot Paul
    Ownership Type:
    Direct Ownership
    Securities:
    Special Warrants
    Nature of Transaction:
    16 - Acquisition or disposition under a prospectus exemption
    # or value acquired/disposed of:
    208,333
    Price:
    $0.12
  • Nov 05, 2020 (filed on Nov 10, 2020)
    Insider Name:
    Cashman, Neil
    Ownership Type:
    Direct Ownership
    Securities:
    Special Warrants
    Nature of Transaction:
    16 - Acquisition or disposition under a prospectus exemption
    # or value acquired/disposed of:
    208,333
    Price:
    $0.12
  • Nov 05, 2020 (filed on Nov 10, 2020)
    Insider Name:
    Williams, Eugene Warren
    Ownership Type:
    Direct Ownership
    Securities:
    Special Warrants
    Nature of Transaction:
    16 - Acquisition or disposition under a prospectus exemption
    # or value acquired/disposed of:
    208,333
    Price:
    $0.12
Comment by Fryinpan on Nov 10, 2020 5:13pm
Encouraging insider activity.  That said: where the heck is Johannes Minho Roth and Richard Gregory?  In fact, Roth is a money manager who apparently continues to maintain minimal holdings in PMN.  Roth is an embarassment.  
Comment by M101 on Nov 10, 2020 5:41pm
I'm just thrilled these execs are willing to commit 2 weeks's salary to tell the rest of the market not to buy (absent warrants) above 10 cents.   
Comment by retiredcop on Nov 10, 2020 6:02pm
Its Roth's connection to PowerPLug that has helped PMN. He brought over quite a few very big investors from there when he came onto the board of PMN. He unfortunately was referred to PMN  by Hans Black, who ungracefully left us a number of years ago. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities